Documentation for Hybrid CNN + LSTM Model "Biohackthon Sole 11"
This documentation provides an overview of our model, including data preprocessing, model architecture, training process and evaluation.

1. Project Overview
This project builds a Hybrid CNN + LSTM Model for SARS-CoV-2 variant classification based on genomic signatures. The model combines Convolutional Neural Networks (CNNs) for feature extraction and Long Short-Term Memory Networks (LSTMs) for sequential pattern recognition.
------------------------------------------------------------------------------------------
2. Data Preprocessing
Files Used
	train.csv ‚Üí Training dataset.
	test_features.csv ‚Üí Testing dataset.
Preprocessing Steps
	1-Load Data
	
	Reads training and test data from CSV files using pandas.

	2-Feature Selection

	Selects only numeric features for model input.

	3-Label Encoding

	Converts target labels (variants) into numerical format using LabelEncoder().

	4-Class Balancing

	Uses SMOTE (Synthetic Minority Oversampling Technique) to balance class distribution.

	5-Feature Scaling

	Standardizes input features using StandardScaler() to improve model convergence.

	6-Data Splitting

	Splits the dataset into 80% training and 20% validation using train_test_split().
------------------------------------------------------------------------------------------
3. Model Architecture
This model integrates CNN and LSTM layers to leverage both spatial and sequential dependencies in genomic data.

Architecture Breakdown
1-CNN Layers
	Conv1D (64 filters, kernel size = 3, ReLU)
	Conv1D (128 filters, kernel size = 3, ReLU)
	MaxPooling1D (pool size = 2)
	Flatten Layer (converts feature maps into a 1D vector)

2-LSTM Layers
	Reshapes data for LSTM compatibility.
	LSTM (128 units, return_sequences=True)
	LSTM (64 units)

3-Fully Connected Layers
	Dense (128 neurons, ReLU)
	Dropout (rate = 0.3) for regularization.
	Output Layer (Softmax Activation) ‚Üí Classifies input into multiple SARS-CoV-2 variants.
------------------------------------------------------------------------------------------
4. Model Compilation & Training

Compilation
	Loss Function: sparse_categorical_crossentropy (suitable for multi-class classification).
	Optimizer: Adam(learning_rate=0.001) (adaptive optimization).
	Evaluation Metric: accuracy.

Training
	EarlyStopping: Stops training when validation loss does not improve for 5 consecutive epochs.
	ReduceLROnPlateau: Reduces the learning rate if validation loss stagnates, improving model stability.
------------------------------------------------------------------------------------------
5. Model Evaluation

Classification Report
	Generates a classification report with precision, recall, and F1-score.
AUC-ROC Curve
	Evaluates the model‚Äôs ability to distinguish between different SARS-CoV-2 variants.
------------------------------------------------------------------------------------------
6. Improvements & Future Work

‚úÖ Strengths
	Combines CNN + LSTM for feature extraction and sequential modeling.
	Handles class imbalance using SMOTE.
	Optimized training process with early stopping and adaptive learning rate.
üîπ Potential Enhancements
	Hyperparameter tuning with Keras Tuner to optimize architecture.
	Cross-validation to improve generalization.
	Feature importance analysis using SHAP for model interpretability.
	Comparison with Transformer-based models (e.g., BioBERT, LSTNet).
------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------
‚£∂‚£∂‚£∂‚£∂‚£∂‚£ñ‚£í‚°Ñ‚†Ä‚£∂‚°ñ‚†≤‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢†‚£§‚††‚°Ñ‚†Ä‚†Ä‚†Ä‚†Ä
‚†ô‚†õ‚£ø‚£ø‚£ø‚°ü‚†õ‚†É‚¢Ä‚£ø‚£ø‚£Ü‚£¶‚£¥‚†Ç‚†§‚†Ä‚†Ä‚†Ä‚£†‚£§‚£¥‚£Ü‚††‚¢Ñ‚†Ä‚†Ä‚†Ä‚£§‚°§‚¢§‚£§‚£§‚†§‚¢Ñ‚†Ä‚†Ä‚¢ª‚£ø‚£¶‚°á‚¢Ä‚£§‚¢§‚†Ä
‚†Ä‚¢Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†õ‚£ø‚£∑‚£Ñ‚°á‚†Ä‚£º‚£ø‚£ø‚°ü‚¢ø‚£∑‚°Ñ‚££‚†Ä‚¢ò‚£ø‚£ø‚£ø‚†ø‚£ø‚£ß‚£à‚°Ü‚†Ä‚¢π‚£ø‚£ø‚£∑‚£æ‚£ß‚£¥‚†Ä
‚†Ä‚¢∞‚£ø‚£ø‚£ø‚†Ä‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚†ô‚†õ‚£ª‚£ß‚£æ‚£ø‚£ø‚°∑‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚¢∏‚£ø‚£ø‚£ø‚£ø‚£ø‚°á‚†Ä
‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚°ø‚†Ä‚£ø‚£ø‚£ø‚†É‚†Ä‚£∞‚£æ‚£ø‚°ø‚£ø‚£ø‚£ø‚£ü‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚¢∏‚£ø‚£ø‚£ø‚£ø‚°è‚¢á‚†Ä
‚†Ä‚£º‚£ø‚£ø‚£ø‚†Ä‚†Ä‚†Ä‚£∏‚£ø‚£ø‚£ü‚¢†‚£ø‚£ø‚£ø‚†Ä‚†Ä‚£ø‚£ø‚°ü‚£á‚£æ‚£ø‚£ø‚£Ø‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚¢º‚£ø‚£ø‚£ø‚£ø‚£∑‚°à‚°Ä
‚†Ä‚†ª‚†ø‚†ø‚†ü‚†Ä‚†Ä‚†Ä‚†ª‚†ø‚†ø‚†è‚†∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚¢ø‚£ø‚£ø‚£ø‚£ø‚£ø‚£ø‚°á‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚£ø‚£ø‚£ø‚°ü‚¢ª‚£ø‚£ß‚£á
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†â‚†Ä‚†Ä‚†â‚†â‚†Ä‚†Ä‚†Ä‚†â‚†â‚†Å‚†Ä‚†â‚†â‚†â‚†Ä‚†Ä‚†ò‚†ô‚†ã‚†Å‚†à‚†ã‚†õ‚†â
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢Ä‚£†‚£§‚°Ä‚†Ä‚¢Ä‚£Ä‚£Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢Ä‚£§‚°§‚††‚°Ñ‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢π‚£ø‚£Ñ‚†±‚£†‚£ø‚£ß‚£¥‚†Ä‚†Ä‚£†‚£§‚£§‚£Ä‚£Ä‚°Ä‚†Ä‚†Ä‚¢Ä‚£§‚†§‚°Ä‚¢Ä‚£†‚°§‚¢Ñ‚†Ä‚†à‚£ø‚£ø‚£¶‚°á‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†à‚¢ø‚£ø‚£∑‚£ø‚£ø‚£ø‚°è‚†Ä‚£æ‚£ø‚£ø‚£ø‚£∂‚£Ñ‚°â‚°Ñ‚†Ä‚£ø‚£ø‚£§‚£ù‚¢∏‚£ø‚£¶‚£º‚†Ä‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢ø‚£ø‚£ø‚£ø‚†è‚†Ä‚†ê‚£ø‚£ø‚£ø‚†â‚£ø‚£ø‚£∑‚°á‚†Ä‚£Ω‚£ø‚£ø‚£Ø‚¢∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚¢π‚£ø‚£ø‚°á‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚¢†‚£ø‚£ø‚£ø‚†Ä‚£ø‚£ø‚£ø‚°á‚†Ä‚£ª‚£ø‚£ø‚°∑‚¢∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚†á‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚¢∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚†Ä‚¢ø‚£ø‚£ø‚£Ñ‚£ø‚£ø‚£ø‚†á‚†Ä‚¢π‚£ø‚£ø‚£ø‚£∏‚£ø‚£ø‚£ø‚†Ä‚†Ä‚¢†‚£Ω‚£ß‚°Ñ‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†õ‚†õ‚†ã‚†Ä‚†Ä‚†Ä‚†à‚†õ‚†õ‚†õ‚†õ‚†õ‚†â‚†Ä‚†Ä‚†à‚†õ‚†õ‚†õ‚†ã‚†õ‚†õ‚†ã‚†Ä‚†Ä‚†à‚†õ‚†õ‚†Å‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä‚†Ä
